REGIONAL VARIATION IN SEVERE ASTHMA PREVALENCE AND ORAL CORTICOSTEROID USE FOR PATIENTS IN AUSTRALIA: HEAT MAP ANALYSIS

被引：0
|
作者：
Wark, P. [1 ]
Hew, M. [2 ,3 ]
Xu, Y. [4 ]
Ghisla, C. [5 ]
Nguyen, T.
Erdemli, B. [6 ]
Samant, A.
Nan, C. [7 ]
机构：
[1] Univ Newcastle, Hunter Med Res Inst, Ctr Healthy Lungs, New Lambton Hts, Australia
[2] Monash Univ, Publ Hlth & Prevent Med, Melbourne, Vic, Australia
[3] Alfred Hosp, Melbourne, Vic, Australia
[4] AstraZeneca, Resp Inhaled, Cambridge, England
[5] AstraZeneca, Resp Inflammat & Autoimmun, Sydney, NSW, Australia
[6] ZS Associates, Zurich, Switzerland
[7] AstraZeneca, Med Evidence & Observat Res, Molndal, Sweden
来源：
RESPIROLOGY | 2021年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：84 / 84
页数：1
相关论文
共 50 条
  • [31] Cost and Healthcare Utilization in Asthma Patients with High Oral Corticosteroid Use
    Raimundo, Karina
    Ngai, Ka M.
    Chang, Eunice
    Broder, Michael
    Griffin, Noelle M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB5 - AB5
  • [32] Dupilumab Reduces Oral Corticosteroid Use and Severe Exacerbations and Improves Lung Function in Patients With Oral Corticosteroid-Dependent Severe Asthma With and Without Comorbid Allergic Rhinitis in the Phase 3 LIBERTY ASTHMA VENTURE Study
    Castro, Mario
    Maspero, Jorge
    Sher, Lawrence
    Rabe, Klaus
    Casale, Thomas
    Rice, Megan
    Ruddy, Marcella
    Rowe, Paul
    Deniz, Yamo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB173 - AB173
  • [33] Risk of corticosteroid-related adverse events in asthma patients with high oral corticosteroid use
    Zazzali, James L.
    Broder, Michael S.
    Omachi, Theodore A.
    Chang, Eunice
    Sun, Gordon H.
    Raimundo, Karina
    ALLERGY AND ASTHMA PROCEEDINGS, 2015, 36 (04) : 268 - 274
  • [34] Interim analysis of a prospective study investigating oral corticosteroid (OCS) use in omalizumab treated severe allergic asthma patients: APEX II study
    Niven, Rob
    Bucknall, Christine
    Chaudhuri, Rekha
    Kurukulaaratchy, Ramesh
    De Lorio, Fosca
    Menzies-Gow, Andrew
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [35] Oral corticosteroid sparing with omalizumab in severe allergic (IgE-mediated) asthma patients
    Siergiejko, Zenon
    Swiebocka, Ewa
    Smith, Nicola
    Peckitt, Clare
    Leo, Jo
    Peachey, Guy
    Maykut, Robert
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (11) : 2223 - 2228
  • [36] Phenotype and biomarkers in patients who initiated biologics therapy stratified by oral corticosteroid use in the International Severe Asthma Registry
    Torres-Duque, Carlos A.
    Chan, Jeffrey Shi Kai
    Fletton, Kirsty
    Townend, John
    Dorscheid, Delbert R.
    Altraja, Alan
    Ulrik, Charlotte Suppli
    Beastall, Aaron
    Goh, Celine
    Navaratnam, Vidya
    Bulathsinhala, Lakmini
    Carter, Victoria
    Wang, Zhixiao
    Gall, Rebecca
    Cheng, Wei-Han
    Aarli, Bernt Bogvald
    Bergeron, Celine
    Bourdin, Arnaud
    Bulkhi, Adeeb A.
    Christoff, George C.
    Fonseca, Joao A.
    Jenkins, Christine
    Koh, Mariko Siyue
    Kostikas, Konstantinos
    Loukides, Stelios
    Pleasants, Roy Alton
    Popov, Todor A.
    Ryan, Dermot
    Solarte, Ivan
    Tsai, Ming-Ju
    Maldonado, Libardo Jimenez
    Kuna, Piotr
    Louis, Renaud
    Mahboub, Bassam
    Murray, Ruth B.
    Pitrez, Paulo Marcio
    Puggioni, Francesca
    Al-Ahmad, Mona
    Bjermer, Leif
    Bjornsdottir, Unnur S.
    Cosio, Borja G.
    Costello, Richard W.
    Csoma, Zsuzsanna
    Iwanaga, Takashi
    Larenas-Linnemann, Desiree
    Lehtimaki, Lauri
    Sivori, Martin
    Rhee, Chin Kook
    Salvi, Sundeep
    Taube, Christian
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [37] The prevalence of severe asthma, use of oral corticosteroid and management strategies in the Nordic countries: results from the pan-Nordic NORDSTAR cohort
    Hansen, S.
    Von Bulow, A.
    Sandin, P.
    Ernstsson, O.
    Wahl, H. Fues
    Geale, K.
    Janson, C.
    Lehtimaki, L.
    Kankaanranta, H.
    Ulrik, C.
    Aarli, B. Bogvald
    Tang, S. Tuyet
    Wolf, M.
    Larsen, T.
    Backer, V.
    Backman, H.
    Karjalainen, J.
    Altraja, A.
    Viinanen, A.
    Yasinska, V.
    Skjold, T.
    Schmid, J.
    Kauppi, P.
    Ludviksdottir, D.
    Lehmann, S.
    Sverrild, A.
    Kilpelainen, M.
    Boissos, A.
    Porsbjerg, C.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [38] Discrimination between oral corticosteroid-treated and oral corticosteroid-non-treated severe asthma patients by an electronic nose platform
    Santini, Giuseppe
    Di Carlo, Stefano
    Benso, Alfredo
    Mores, Nadia
    Brinkman, Paul
    Valente, Salvatore
    Montuschi, Paolo
    Macagno, Francesco
    Wagener, Ariane H.
    Bansal, Aruna T.
    Pandis, Ioannis
    Knobel, Hugo H.
    Vink, Anton J.
    Rattray, Nicholas
    Santonico, Marco
    Pennazza, Giorgio
    Guo, Yi-Ke
    Horvath, Ildiko
    Djukanovic, Ratko
    Polosa, Riccardo
    Sousa, Ana R.
    Corfield, Julie
    Rowe, Anthony
    Fowler, Stephen J.
    Chanez, Pascal
    Chung, Kian Fan
    Sterk, Pater J.
    Montuschi, Paolo
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [39] Complications related to oral corticosteroid use in asthma patients: a retrospective cohort study
    Lai, Chih-Cheng
    Chen, Chao-Hsien
    Wang, Ya-Hui
    Wang, Cheng-Yi
    Wang, Hao-Chien
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2025, 18 (04) : 225 - 236
  • [40] Prevalence of long-term oral corticosteroid use in asthma evaluated from different angles
    Tran, Trung N.
    MacLachlan, Sharon
    Ganz, Michael
    Hicks, Wesley
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 542 - 542
12345